SCHEMBL21031437

SCHEMBL21031437

c1cnc2c(c1)ccc1ccc(-c3c4ccccc4nc4c3sc3ccccc34)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KRAS P01116 1/20 0.41
LMNA P02545 4/20 0.39
KDM4E B2RXH2 5/20 0.39
CCR1 P32246 4/20 0.39
CCR8 P51685 4/20 0.39
MAPT P10636 3/20 0.39
TP53 P04637 3/20 0.39
CYP3A4 P08684 2/20 0.39
TSHR P16473 2/20 0.39
CCR5 P51681 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HSP90AA1 P07900 2/20 0.39
ALOX15 P16050 2/20 0.39
HTT P42858 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
GMNN O75496 1/20 0.39
MMP2 P08253 1/20 0.39
CYP2D6 P10635 1/20 0.39
MMP9 P14780 1/20 0.39
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21032091 0.91 KRAS (0.38) KRASLMNAKDM4ECCR1CCR8
SCHEMBL25847629 0.88 TOP1 (0.38) KRASLMNAKDM4ECCR1CCR8
SCHEMBL25847632 0.86 TNKS (0.36) KRASESR1LIMK1CDK5CDK5R1
SCHEMBL21031436 0.84 TOP1 (0.35) KRASLMNAKDM4EMAPTALDH1A1
SCHEMBL21031299 0.82 LMNA (0.38) LMNAKDM4ECCR1CCR8MAPT
SCHEMBL21032364 0.81 LMNA (0.36) KRASLMNAKDM4ECCR1CCR8
SCHEMBL21119902 0.81 LMNA (0.40) KRASLMNAKDM4ECCR1CCR8
SCHEMBL21030692 0.80 TNKS (0.38) KRASKDM4EMAPTTP53SMN1; SMN2
SCHEMBL20208145 0.78 CCR1 (0.44) LMNAKDM4ECCR1CCR8MAPT
SCHEMBL21119848 0.77 LMNA (0.41) KRASLMNAKDM4ECCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 KRAS 3523/4885LMNA 2539/4885KDM4E 962/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 KRAS 3523/4885LMNA 2539/4885KDM4E 962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.